Principal Investigator
Jay Spiegel
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20230769
Clinical Trial Summary
A Phase 1 Open-label, Single Arm, Multicenter Study Evaluating the Safety and Efficacy of KITE-197 in Subjects with Relapsed or Refractory Large B-cell Lymphoma
Phase
Phase I
Funding Agency/Sponsor
Industrial
Disease
Transplant/cellular therapy
Contact Information
Phone Number
305-243-2647